• 214 Citations
  • 8 h-Index
20042019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Daijyu Ichikawa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences
Thalidomide Medicine & Life Sciences
Cells Chemical Compounds
Apoptosis Chemical Compounds
Focal Adhesion Protein-Tyrosine Kinases Medicine & Life Sciences
Derivatives Chemical Compounds
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 214 Citations
  • 8 h-Index
  • 20 Article
1 Citation (Scopus)
Cell Separation
Hydrogel
Hydrogels
Silicon Dioxide
beads

A novel derivative (GTN024) from a natural product, komaroviquinone, induced the apoptosis of high-risk myeloma cells via reactive oxygen production and ER stress

Okayama, M., Kitabatake, S., Sato, M., Fujimori, K., Ichikawa, D., Matsushita, M., Suto, Y., Iwasaki, G., Yamada, T., Kiuchi, F., Hirao, M., Kunieda, H., Osada, M., Okamoto, S. & Hattori, Y., 2018 Nov 2, In : Biochemical and Biophysical Research Communications. 505, 3, p. 787-793 7 p.

Research output: Contribution to journalArticle

Endoplasmic Reticulum Stress
Biological Products
Multiple Myeloma
Apoptosis
Oxygen
2 Citations (Scopus)

Early generated B-1–derived B cells have the capacity to progress to become mantle cell lymphoma–like neoplasia in aged mice

Hayakawa, K., Formica, A. M., Nakao, Y., Ichikawa, D., Shinton, S. A., Brill-Dashoff, J., Smith, M. R., Morse, H. C. & Hardy, R. R., 2018 Jul 15, In : Journal of Immunology. 201, 2, p. 804-813 10 p.

Research output: Contribution to journalArticle

B-Lymphocytes
Neoplasms
Lymph Nodes
Intestines
Mantle-Cell Lymphoma

A novel phenylphthalimide derivative, pegylated TC11, improves pharmacokinetic properties and induces apoptosis of high-risk myeloma cells via G2/M cell-cycle arrest

Aida, S., Hozumi, M., Ichikawa, D., Iida, K., Yonemura, Y., Tabata, N., Yamada, T., Matsushita, M., Sugai, T., Yanagawa, H. & Hattori, Y., 2017, (Accepted/In press) In : Biochemical and Biophysical Research Communications.

Research output: Contribution to journalArticle

G2 Phase Cell Cycle Checkpoints
Pharmacokinetics
Multiple Myeloma
Polyethylene glycols
Cells
1 Citation (Scopus)

CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients

Matsushita, M., Ozawa, K., Suzuki, T., Nakamura, M., Nakano, N., Kanchi, S., Ichikawa, D., Matsuki, E., Sakurai, M., Karigane, D., Kasahara, H., Tsukamoto, N., Shimizu, T., Mori, T., Nakajima, H., Okamoto, S., Kawakami, Y. & Hattori, Y., 2017 Sep 1, In : Blood Cancer Journal. 7, 9, e601.

Research output: Contribution to journalArticle

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Protein-Tyrosine Kinases
Stem Cells
Therapeutics
T-Lymphocytes